Clinical trial

Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors

NCT05858736

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2023-07-11

PhasePHASE1

Study timeline

Study start (actual)2023-07-11Date precision: day

Registry last updated2026-09-14

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Melanomaunresolved

Non Small Cell Lung Cancerunresolved

Head and Neck Squamous Cell Carcinomaunresolved

High Grade Serous Adenocarcinoma of Ovaryunresolved

Primary Peritoneal Carcinomaunresolved

Fallopian Tube Cancerunresolved

Endometrial Cancerunresolved

Cervical Cancerunresolved

Renal Cell Carcinomaunresolved

Bladder Cancerunresolved

Esophageal Cancerunresolved

Gastric Cancerunresolved

Gastroesophageal-junction Cancerunresolved

Colorectal Cancerunresolved

Anal Cancerunresolved

Hepatocellular Carcinomaunresolved

Bile Duct Cancerunresolved

Interventions

Sponsors & collaborators

OncoC4, Inc.lead sponsor

OncoC4 AU Pty Ltdcollaborator

Avance Clinical Pty Ltd.collaborator

Mapped research locations

AdelaideSouth Australia, Australia1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05858736 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.